Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
66.14
-0.57 (-0.85%)
At close: Apr 20, 2026, 4:00 PM EDT
66.45
+0.31 (0.47%)
After-hours: Apr 20, 2026, 5:27 PM EDT
Cytokinetics Analyst Ratings
Total Analysts
19
Consensus Rating
Strong Buy
Price Target
$89.26
Upside
+34.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $95 | Buy | Initiates | $95 | +43.63% | Apr 10, 2026 |
| Barclays | Barclays | Buy Maintains $87 → $95 | Buy | Maintains | $87 → $95 | +43.63% | Apr 6, 2026 |
| Mizuho | Mizuho | Buy Maintains $84 → $100 | Buy | Maintains | $84 → $100 | +51.19% | Mar 18, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $74 → $75 | Buy | Maintains | $74 → $75 | +13.40% | Mar 17, 2026 |
| UBS | UBS | Hold Maintains $61 → $69 | Hold | Maintains | $61 → $69 | +4.32% | Mar 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $83 → $84 | Buy | Maintains | $83 → $84 | +27.00% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $88 → $96 | Buy | Maintains | $88 → $96 | +45.15% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $84 → $85 | Strong Buy | Maintains | $84 → $85 | +28.52% | Feb 25, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $95 → $101 | Buy | Maintains | $95 → $101 | +52.71% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $84 → $92 | Strong Buy | Maintains | $84 → $92 | +39.10% | Feb 3, 2026 |
| Barclays | Barclays | Buy Initiates $87 | Buy | Initiates | $87 | +31.54% | Jan 28, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $90 → $108 | Strong Buy | Maintains | $90 → $108 | +63.29% | Jan 21, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +43.63% | Jan 21, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $70 → $74 | Buy | Maintains | $70 → $74 | +11.88% | Jan 20, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $71 | Buy | Maintains | $65 → $71 | +7.35% | Dec 23, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $87 → $95 | Buy | Maintains | $87 → $95 | +43.63% | Dec 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.